CUSIP 252131AM9NOTE 0.375% 5/1DXCMQ4 2025
55 reported transactions
| # | Date | Insider | Title | Type | Shares | Price | Value | Held After | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Jun 4, 2026 | Coleman Jon | EVP, Chief Commercial Officer | S · Sell | 4.9K | $74.13 | $364.1K | 95.5K | SEC |
| 2 | Jun 3, 2026 | Coleman Jon | EVP, Chief Commercial Officer | S · Sell | 4.9K | $73.00 | $358.6K | 100.4K | SEC |
| 3 | May 28, 2026 | Altman Steven R | Director | A · Grant | 5.6K | $0.00 | $0 |
See the full Form 4 transaction history for Dexcom Inc.
Unlock all transactions| 5.6K |
| SEC |
| 4 | May 28, 2026 | Malady Kyle | Director | A · Grant | 5.6K | $0.00 | $0 | 28.2K | SEC |
| 5 | May 28, 2026 | Augustinos Nicholas | Director | A · Grant | 5.6K | $0.00 | $0 | 5.6K | SEC |
| 6 | May 28, 2026 | Foletta Mark G | Director | A · Grant | 6.3K | $0.00 | $0 | 6.3K | SEC |
| 7 | May 28, 2026 | Heller Bridgette P | Director | A · Grant | 5.6K | $0.00 | $0 | 30.6K | SEC |
| 8 | May 28, 2026 | Osterloh Albert Frederick IV | Director | A · Grant | 1.6K | $0.00 | $0 | 8.7K | SEC |
| 9 | May 28, 2026 | Driscoll Rimma | Director | A · Grant | 5.6K | $0.00 | $0 | 17.3K | SEC |
| 10 | May 28, 2026 | Ashley Euan A. | Director | A · Grant | 5.6K | $0.00 | $0 | 12.7K | SEC |